Newsletters
ePaper
Sign in
Home
India
Assembly Polls 2024
Karnataka
Opinion
World
Business
Sports
Entertainment
Video
News Shots
Explainers
Bengaluru
Science
Trending
Photos
Brandspot
DH Specials
Home
News Shots
Trending
Menu
×
ADVERTISEMENT
ADVERTISEMENT
Corbevax
Corbevax vaccine gets WHO Emergency Use Listing authorisation
BE has recently received final approval from CDSCO to begin clinical trials of the XBB.1.5 variant vaccine in India.
16 January 2024, 12:52 IST
Corbevax vaccine gets WHO Emergency Use Listing authorisation
16 January 2024, 12:52 IST
Covishield + Corbevax booster protects against variants
Only 27 to 28 per cent of India's eligible population have taken the booster dose
25 December 2022, 10:59 IST
Covishield + Corbevax booster protects against variants
25 December 2022, 10:59 IST
Govt nod to Corbevax as heterologous Covid booster shot
This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country
10 August 2022, 18:28 IST
Govt nod to Corbevax as heterologous Covid booster shot
10 August 2022, 18:28 IST
NTAGI recommends Corbevax as Covid booster for adults
Corbevax is currently being used to inoculate children in the age group of 12 to 14 years under the Covid-19 Immunisation programme
02 August 2022, 13:21 IST
NTAGI recommends Corbevax as Covid booster for adults
02 August 2022, 13:21 IST
NTAGI may consider Corbevax as heterologous booster vax
DCGI on June 4 approved Corbevax as a precaution dose for those aged 18 and above
27 June 2022, 15:53 IST
NTAGI may consider Corbevax as heterologous booster vax
27 June 2022, 15:53 IST
DH Evening Brief: India approves Corbevax as 1st heterologous Covid booster; Police make third arrest in Hyderabad gang-rape case
Here are the top stories this evening.
04 June 2022, 13:33 IST
DH Evening Brief: India approves Corbevax as 1st heterologous Covid booster; Police make third arrest in Hyderabad gang-rape case
04 June 2022, 13:33 IST
Biological E cuts price of Corbevax to Rs 250 per dose
It would result in end users paying a price of Rs 400 a dose, including taxes and administration charges
16 May 2022, 08:58 IST
Biological E cuts price of Corbevax to Rs 250 per dose
16 May 2022, 08:58 IST
Corbevax vs Covovax jabs under 18 yrs: Which to choose?
The vaccines will join Bharat Biotech's Covaxin, which is currently available for inoculation of the 12-18 age group and has been given EUA for the 6-12 age group
30 April 2022, 11:28 IST
Corbevax vs Covovax jabs under 18 yrs: Which to choose?
30 April 2022, 11:28 IST
Covid vax of 12-14 age group sees low turnout on Day 1
Day one of the exercise saw children arriving largely through 'walk-in for vaccination' and the numbers were very few at session sites
16 March 2022, 09:53 IST
Covid vax of 12-14 age group sees low turnout on Day 1
16 March 2022, 09:53 IST
Corbevax vaccine trials on at three sites in Karnataka
Among the ten trial sites, three are in Karnataka - one in Belagavi and two in Mysuru
16 March 2022, 06:48 IST
Corbevax vaccine trials on at three sites in Karnataka
16 March 2022, 06:48 IST
<
1
2
>
